Electrochemically activated chemotherapy (EAC) is two things:

A natural philosophy school of biomimetic pharmaceutical design; and, 
A type of chemical ablation surgery that uses a chemotherapeutic galvanostat/potentiostat.

EAC is the only biomimetic technique that uses electrochemistry as a mechanism of prodrug activation. 

EAC is sometimes also referred to as electroactivated chemotherapy, artificial bioactivation, or electrodrugs, but they're all EAC.

​

EAC can use any type of redox reactive prodrug including antibodies, proteins, small molecules, inorganic molecules and ions, and DNA and RNA.

​

Using The Joey™, individuals and teams are able to develop and test redox sensitive drugs for further market development, going so far as to design electro-reactive chaperone leaving groups to active molecules, as with the case of cyclophosphamide, a World Health Organization anti-cancer molecule in-use since the 1960s.

​